Menu
Back to User profile » Prof. Dr. Qi Pei
Papers published by Prof. Dr. Qi Pei:
A Review of Population Pharmacokinetic Models of Posaconazole
Ding Q, Huang S, Sun Z, Chen K, Li X, Pei Q
Drug Design, Development and Therapy 2022, 16:3691-3709
Published Date: 20 October 2022
Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease
Fu C, Pei Q, Liang W, Yang B, Li W, Liu J, Tan H, Guo C, Zhang H, Yang G
Drug Design, Development and Therapy 2022, 16:2261-2274
Published Date: 13 July 2022
Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets
Feng Z, Liu Y, Kuang Y, Yang S, Li J, Ye L, Huang J, Pei Q, Huang Y, Yang G
Drug Design, Development and Therapy 2022, 16:3-12
Published Date: 3 January 2022
Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
Wang MN, Yu HT, Li YQ, Zeng Y, Yang S, Yang GP, Pei Q, Huang J
Drug Design, Development and Therapy 2021, 15:185-193
Published Date: 14 January 2021
Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study
Wang J, Huang J, Yang S, Cui C, Ye L, Wang S, Yang G, Pei Q
Drug Design, Development and Therapy 2019, 13:4135-4144
Published Date: 6 December 2019
Pharmacokinetics of single- and multiple-dose roflumilast: an open-label, three-way crossover study in healthy Chinese volunteers
Huang J, Fu CX, Yang XY, Cui C, Yang S, Kuang Y, Guo CX, Hu P, Pei Q, Yang GP
Drug Design, Development and Therapy 2018, 12:4047-4057
Published Date: 26 November 2018